Vestibular Schwannoma Drug Development: Current State-of-the Art

Keyphrases

• Drug Development 100%
• Vestibular Schwannoma 100%
• Receptor Signaling 40%
• Signaling Molecules 20%
• Mitogen-activated Protein Kinase 20%
• Mammalian Target of Rapamycin (mTOR) 20%
• Tumorigenesis 20%
• Human Trials 20%
• Treatment Options 20%
• Animal Experiment 20%
• Cell Culture Model 20%
• Cell Surface Receptor 20%
• Intracellular Signaling 20%
• Patient Morbidity 20%
• Schwann Cells 20%
• Platelet-derived Growth Factor Receptor (PDGFR) 20%
• Medical Treatment 20%
• ErbB Receptors 20%
• Stereotactic Body Radiation Therapy 20%
• PAK1 20%
• Kinase Signaling 20%
• VEGF Signaling 20%
• Key Cells 20%

Medicine and Dentistry

• Vestibular Schwannoma 100%
• Kinase Signaling 40%
• Clinical Trial 20%
• Epidermal Growth Factor Receptor 20%
• Signal Transduction 20%
• Carcinogenesis 20%
• Signaling Molecule 20%
• Mitogen-Activated Protein Kinase 20%
• Cell Culture 20%
• Combination Therapy 20%
• Cell Surface Receptor 20%
• Intracellular Signaling 20%
• Platelet Derived Growth Factor Receptor 20%
• P21 Activated Kinase 20%
• mTOR Signaling 20%
• VEGF Signaling 20%
• Stereotactic Radiation Therapy 20%